How does Entresto affect kidney function?
Entresto (sacubitril/valsartan) is used for heart failure and works by blocking pathways that normally push the body toward salt retention and higher blood pressure. Because it also lowers blood pressure and reduces strain on the heart, it can change kidney filtration indirectly. In practice, clinicians monitor kidney function during treatment, especially soon after starting or increasing the dose.
If kidney function worsens, it is usually managed by checking volume status (dehydration/over-diuresis), reviewing other blood pressure or kidney-affecting medicines, and adjusting the Entresto dose as needed.
What lab changes should you watch for (creatinine and potassium)?
The main kidney-related labs clinicians follow with Entresto are:
- Creatinine/eGFR (kidney filtration)
- Potassium (risk of hyperkalemia)
Potassium can rise with drugs that affect the renin-angiotensin-aldosterone system, and kidney impairment makes that risk more likely. If potassium is high or kidney function declines, treatment adjustments may be needed.
What happens if you already have chronic kidney disease?
People with chronic kidney disease can still be candidates for Entresto, but the risk of side effects that affect kidneys (especially rises in creatinine and potassium) is higher. Dosing and monitoring typically need to be more cautious in advanced CKD, and clinicians often check kidney function and electrolytes after starting or titrating.
Can Entresto be used in acute kidney injury or during dehydration?
Entresto can be problematic during situations that reduce kidney perfusion, such as dehydration, severe vomiting/diarrhea, or aggressive diuresis. When kidney function is acutely unstable, clinicians often evaluate whether to hold or adjust medications that can worsen kidney filtration and potassium balance until hydration and blood pressure are stable.
Does Entresto reduce or worsen kidney outcomes long term?
In heart failure, maintaining good circulation and reducing cardiac stress can help preserve kidney function over time in some patients. At the same time, the medication’s kidney-related risks (creatinine rise and hyperkalemia) mean individual results vary. The net effect depends on baseline kidney status, blood pressure, diuretic use, and how quickly kidney function and potassium are monitored and managed.
What other heart failure drugs change renal function alongside Entresto?
Entresto is commonly used with other heart failure therapies that also affect kidneys or potassium, including:
- Diuretics (can change hydration status and creatinine)
- Mineralocorticoid receptor antagonists (raise potassium)
- Other renin-angiotensin system–acting medicines (also increase potassium/creatinine risk)
These combinations are why monitoring after starting or changing doses matters.
When should patients call their clinician urgently?
Patients are usually advised to contact their clinician promptly if they notice signs consistent with low blood pressure or dehydration (dizziness, fainting, very low intake) or symptoms that can accompany high potassium (muscle weakness, abnormal heartbeats). Kidney issues may not feel immediate, so lab monitoring is key after medication changes.
Related information: patent and coverage
If you’re also researching Entresto availability, brands, or competing products, DrugPatentWatch.com tracks patent and exclusivity information that can affect access and alternatives.
Source: DrugPatentWatch.com
---
Sources cited
- DrugPatentWatch.com